<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39355865</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Epidemiology and infection</Title><ISOAbbreviation>Epidemiol Infect</ISOAbbreviation></Journal><ArticleTitle>Risk factors for COVID-19 transmission in England: a multilevel modelling study using routine contact tracing data.</ArticleTitle><Pagination><StartPage>e112</StartPage><MedlinePgn>e112</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e112</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268824001043</ELocationID><Abstract><AbstractText>Contact tracing for COVID-19 in England operated from May 2020 to February 2022. The clinical, demographic and exposure information collected on cases and their contacts offered a unique opportunity to study secondary transmission. We aimed to quantify the relative impact of host factors and exposure settings on secondary COVID-19 transmission risk using 550,000 sampled transmission links between cases and their contacts. Links, or 'contact episodes', were established where a contact subsequently became a case, using an algorithm accounting for incubation period, setting, and contact date. A mixed-effects logistic regression model was used to estimate adjusted odds of transmission. Of sampled episodes, 8.7% resulted in secondary cases. Living with a case (71% episodes) was the most significant risk factor (aOR = 2.6, CI = 1.9-3.6). Other risk factors included unvaccinated status (aOR = 1.2, CI = 1.2-1.3), symptoms, and older age (66-79 years; aOR = 1.4, CI = 1.4-1.5). Whilst global COVID-19 strategies emphasized protection outside the home, including education, travel, and gathering restrictions, this study evidences the relative importance of household transmission. There is a need to reconsider the contribution of household transmission to future control strategies and the requirement for effective infection control within households.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Hannah L</ForeName><Initials>HL</Initials><Identifier Source="ORCID">0000-0002-0289-0014</Identifier><AffiliationInfo><Affiliation>UK Field Epidemiology Training Programme, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Contact Tracing Data Team, UK Health Security Agency, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Kids Research Institute Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Charlie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Contact Tracing Data Team, UK Health Security Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawlinson</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Contact Tracing Data Team, UK Health Security Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Contact Tracing Data Team, UK Health Security Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verlander</LastName><ForeName>Neville Q</ForeName><Initials>NQ</Initials><AffiliationInfo><Affiliation>Contact Tracing Data Team, UK Health Security Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Contact Tracing Data Team, UK Health Security Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Gareth J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Contact Tracing Data Team, UK Health Security Agency, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Infect</MedlineTA><NlmUniqueID>8703737</NlmUniqueID><ISSNLinking>0950-2688</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016358" MajorTopicYN="Y">Contact Tracing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">contact tracing</Keyword><Keyword MajorTopicYN="N">health policy</Keyword><Keyword MajorTopicYN="N">public health</Keyword><Keyword MajorTopicYN="N">transmission</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39355865</ArticleId><ArticleId IdType="pmc">PMC11450508</ArticleId><ArticleId IdType="doi">10.1017/S0950268824001043</ArticleId><ArticleId IdType="pii">S0950268824001043</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oswin HP, Haddrell AE, Otero-Fernandez M, Mann JFS, Cogan TA, Hilditch TG, Tian J, Hardy DA, Hill DJ, Finn A, Davidson AD and Reid JP (2022) The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment. National Academy of Sciences of the United States of America 119(27), e2200109119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9271203</ArticleId><ArticleId IdType="pubmed">35763573</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Xia WY, Jiang F, Liu DY, Lei SQ, Xia ZY and Wu QP (2021) Review of the risk factors for SARS-CoV-2 transmission. World Journal of Clinical Cases 9(7), 1499–1512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7942044</ArticleId><ArticleId IdType="pubmed">33728294</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus JE, Frankel DN, Pawlak MT, Casey TM, Cybulski RJ, Enriquez E, Okulicz JF and Yun HC (2021) Risk factors associated with COVID-19 transmission among US air force trainees in a congregant setting. JAMA Network Open 4(2), e210202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907953</ArticleId><ArticleId IdType="pubmed">33630090</ArticleId></ArticleIdList></Reference><Reference><Citation>Notari A and Torrieri G (2022) COVID-19 transmission risk factors. Pathogens and Global Health 116(3), 146–177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787846</ArticleId><ArticleId IdType="pubmed">34962231</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahi M, Le Pluart D, Beaudet A, Ismael S, Parisey M, Poey N, Tarhini H, Lescure FX, Yazdanpanah Y and Deconinck L (2021) Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France. BMC Infectious Diseases 21(1), 812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8361240</ArticleId><ArticleId IdType="pubmed">34388990</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclerc QJ FN, Knight LE, CMMID COVID-19 Working Group, Funk S and Knight GM (2020) What settings have been linked to SARS-CoV-2 transmission clusters? Wellcome Open Research [Internet] 5, 83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327724</ArticleId><ArticleId IdType="pubmed">32656368</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Kang L, Guo Z, Liu J, Liu M and Liang W (2022) Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: A systematic review and meta-analysis. JAMA Network Open 5(8), e2228008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9396366</ArticleId><ArticleId IdType="pubmed">35994285</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Gui X and Xiong Y (2020) Patients with respiratory symptoms are at greater risk of COVID-19 transmission. Respiratory Medicine 165, 105935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151456</ArticleId><ArticleId IdType="pubmed">32308203</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH and Taiwan C-OIT (2020) Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Internal Medicine 180(9), 1156–1163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195694</ArticleId><ArticleId IdType="pubmed">32356867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LYW, Rozmanowski S, Pang M, Charlett A, Anderson C, Hughes GJ, Barnard M, Peto L, Vipond R, Sienkiewicz A, Hopkins S, Bell J, Crook DW, Gent N, Walker AS, Peto TEA and Eyre DW (2022) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infectivity by viral load, S gene variants and demographic factors, and the utility of lateral flow devices to prevent transmission. Clinical Infectious Diseases 74(3), 407–415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136027</ArticleId><ArticleId IdType="pubmed">33972994</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO (2020) Public Health Criteria to Adjust Public Health and Social Measures in the Context of COVID-19: Annex to Considerations in Adjusting Public Health and Social Measures in the Context of COVID-19. Geneva: WHO. Available at www.apps.who.int/iris/handle/10665/332073.</Citation></Reference><Reference><Citation>Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D and Murray M (2003) Transmission dynamics and control of severe acute respiratory syndrome. Science 300(5627), 1966–1970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2760158</ArticleId><ArticleId IdType="pubmed">12766207</ArticleId></ArticleIdList></Reference><Reference><Citation>Phucharoen C, Sangkaew N and Stosic K (2020) The characteristics of COVID-19 transmission from case to high-risk contact, a statistical analysis from contact tracing data. EClinicalMedicine 27, 100543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7503192</ArticleId><ArticleId IdType="pubmed">32984782</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen H, Tessier E, Turner C, Anderson C, Blomquist P, Simons D, Lochen A, Jarvis CI, Groves N, Capelastegui F, Flannagan J, Zaidi A, Chen C, Rawlinson C, Hughes GJ, Chudasama D, Nash S, Thelwall S, Lopez-Bernal J, Dabrera G, Charlett A, Kall M and Lamagni T (2023) Comparative transmission of SARS-CoV-2 omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: National cohort study, England. Epidemiolgy and Infection 151, e58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10125873</ArticleId><ArticleId IdType="pubmed">36938806</ArticleId></ArticleIdList></Reference><Reference><Citation>Care UDoHaS (2023) Technical report on the COVID-19 pandemic in the UK. London, 10 January 2023.</Citation></Reference><Reference><Citation>Chung H, Kim EO, Kim SH and Jung J (2020) Risk of COVID-19 transmission from infected outpatients to healthcare Workers in an Outpatient Clinic. Journal of Korean Medical Science 35(50), e431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769698</ArticleId><ArticleId IdType="pubmed">33372425</ArticleId></ArticleIdList></Reference><Reference><Citation>Madewell ZJ, Yang Y, Longini IM, Halloran ME and Dean NE (2020) Household transmission of SARS-CoV-2: A systematic review and meta-analysis. JAMA Network Open 3(12), e2031756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737089</ArticleId><ArticleId IdType="pubmed">33315116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciorba Ciorba F, Flores Benitez J, Hernandez Iglesias R, Ingles Torruella J and Olona Cabases MM (2021) Risk factors for COVID-19 transmission among healthcare workers. Archivos de prevencion de riesgod laborales 24(4), 370–382.</Citation><ArticleIdList><ArticleId IdType="pubmed">34965326</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhaeverbeke J, Deprost E, Bonte P, Strobbe M, Nelis J, Volckaert B, Ongenae F, Verstockt S and Van Hoecke S (2023) Real-time estimation and monitoring of COVID-19 aerosol transmission risk in office buildings. Sensors 23(5), 2459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10007635</ArticleId><ArticleId IdType="pubmed">36904663</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrik E and Mease L (2021) Risk mitigation strategies to prevent transmission of COVID-19 in the military classroom setting: A case of a symptomatic SARS-CoV2 positive student without apparent spread to classmates. Medical Journal (Fort Sam Houston, TX) (PB 8-21-01/02/03), pp. 104–107.</Citation><ArticleIdList><ArticleId IdType="pubmed">33666920</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics (2018) Cartographer Public Health England Centres and Public Health England Regions (December 2017) Map in England. Hampshire: Office for National Statistics.</Citation></Reference><Reference><Citation>England PH (2021) Investigation of Novel SARS-CoV-2 Variant Variant of Concern 202012/01 - Technical Briefing 3. London: Public Health England, Group VT; Report No.: 3.</Citation></Reference><Reference><Citation>Ekroth AKE, Patrzylas P, Turner C, Hughes GJ and Anderson C (2022) Comparative symptomatology of infection with SARS-CoV-2 variants omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England. Epidemiolgy and Infection 150, e162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9509793</ArticleId><ArticleId IdType="pubmed">35975466</ArticleId></ArticleIdList></Reference><Reference><Citation>Benndorf V, Kübler D and Normann H-T (2015) Privacy concerns, voluntary disclosure of information, and unraveling: An experiment. European Economic Review 75, 43–59.</Citation></Reference><Reference><Citation>Warner M, Kitkowska A, Gibbs J, Maestre JF and Blandford A (2020) Evaluating ‘Prefer not to say’ around sensitive disclosures. In Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems. New York: ACM, pp. 1–13.</Citation></Reference><Reference><Citation>Powell M (2009) The BOBYQA Algorithm for Bound Constrained Optimization without Derivatives. Cambridge: University of Cambridge, Department of Applied Mathematics and Theoretical Physics CfMaTP.</Citation></Reference><Reference><Citation>Hartig F (2016) DHARMa: Residual diagnostics for hierarchical (multi-level/mixed) regression models. R package version 0.1. 0. CRAN.</Citation></Reference><Reference><Citation>Zhu P, Tan X, Wang M, Guo F, Shi S and Li Z (2023) The impact of mass gatherings on the local transmission of COVID-19 and the implications for social distancing policies: Evidence from Hong Kong. PLoS One 18(2), e0279539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9891527</ArticleId><ArticleId IdType="pubmed">36724151</ArticleId></ArticleIdList></Reference><Reference><Citation>Drury J, Rogers MB, Marteau TM, Yardley L, Reicher S and Stott C (2021) Re-opening live events and large venues after Covid-19 ‘lockdown’: Behavioural risks and their mitigations. Safety Science 139, 105243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8545776</ArticleId><ArticleId IdType="pubmed">34720424</ArticleId></ArticleIdList></Reference><Reference><Citation>Althouse BM, Wenger EA, Miller JC, Scarpino SV, Allard A, Hebert-Dufresne L and Hu H (2020) Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control. PLoS Biology 18(11), e3000897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685463</ArticleId><ArticleId IdType="pubmed">33180773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamner L, Dubbel P, Capron I, Ross A, Jordan A, Lee J, Lynn J, Ball A, Narwal S, Russell S, Patrick D and Leibrand H (2020) High SARS-CoV-2 attack rate following exposure at a choir practice - Skagit County, Washington, March 2020. MMWR: Morbidity and Mortality Weekly Report 69(19), 606–610.</Citation><ArticleIdList><ArticleId IdType="pubmed">32407303</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Eggo RM and Kucharski AJ (2020) Secondary attack rate and superspreading events for SARS-CoV-2. The Lancet 395(10227), e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158947</ArticleId><ArticleId IdType="pubmed">32113505</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauser J, Schwarz C, Morgan J, Jantsch J and Brem M (2021) SARS-CoV-2 transmission during an indoor professional sporting event. Scientific Reports 11(1), 20723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528911</ArticleId><ArticleId IdType="pubmed">34671096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferretti L, Wymant C, Petrie J, Tsallis D, Kendall M, Ledda A, Di Lauro F, Fowler A, Di Francia A, Panovska-Griffiths J, Abeler-Dorner L, Charalambides M, Briers M and Fraser C (2024) Digital measurement of SARS-CoV-2 transmission risk from 7 million contacts. Nature 626(7997), 145–150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10830410</ArticleId><ArticleId IdType="pubmed">38122820</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur R, Rentsch CT, Morton CE, Hulme WJ, Schultze A, MacKenna B, Eggo RM, Bhaskaran K, Wong AYS, Williamson EJ, Forbes H, Wing K, McDonald HI, Bates C, Bacon S, Walker AJ, Evans D, Inglesby P, Mehrkar A, Curtis HJ, DeVito NJ, Croker R, Drysdale H, Cockburn J, Parry J, Hester F, Harper S, Douglas IJ, Tomlinson L, Evans SJW, Grieve R, Harrison D, Rowan K, Khunti K, Chaturvedi N, Smeeth L, Goldacre B and Open SC (2021) Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: An observational cohort study using the OpenSAFELY platform. The Lancet 397(10286), 1711–1724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8087292</ArticleId><ArticleId IdType="pubmed">33939953</ArticleId></ArticleIdList></Reference><Reference><Citation>Slifka MK, Messer WB and Amanna IJ (2020) Analysis of COVID-19 transmission: Low risk of Presymptomatic spread? Archives of Pathology and Laboratory Medicine 144(10), 1161–1162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363133</ArticleId><ArticleId IdType="pubmed">32501120</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong C, Shi W, Zhang A and Shi Z (2023) A spatiotemporal solution to control COVID-19 transmission at the community scale for returning to normalcy: COVID-19 symptom onset risk spatiotemporal analysis. JMIR Public Health and Surveillance 9, e36538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9829029</ArticleId><ArticleId IdType="pubmed">36508488</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>